Apolipoprotein E epsilon4 genotype as a risk factor for cognitive decline and dementia: data from the Canadian Study of Health and Aging (Q30969340)

21 August 2017

Apolipoprotein E epsilon4 genotype as a risk factor for cognitive decline and dementia: data from the Canadian Study of Health and Aging (English)

1 reference

21 August 2017

0 references

1 reference

Ging-Yuek R Hsiung

1

1 reference

21 August 2017

A Dessa Sadovnick

series ordinal

2

1 reference

21 August 2017

Howard Feldman

series ordinal

3

1 reference

21 August 2017

language of work or name

English

0 references

publication date

1 October 2004

1 reference

Canadian Medical Association Journal

21 August 2017

1 reference

21 August 2017

171

1 reference

21 August 2017

8

1 reference

21 August 2017

863-867

1 reference

A model for susceptibility polymorphisms for complex diseases: apolipoprotein E and Alzheimer disease

21 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=522651

Apolipoprotein-E genotype in normal aging, age-associated memory impairment, Alzheimer's disease and vascular dementia patients.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=522651

Apolipoprotein E epsilon4 and the risk of dementia with stroke. A population-based investigation.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=522651

Standardization of the diagnosis of dementia in the Canadian Study of Health and Aging.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=522651

Apolipoprotein E and Alzheimer's disease: strength of association is related to age at onset.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=522651

Apolipoprotein E polymorphism in patients with different neurodegenerative disorders.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=522651

Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=522651

Net economic costs of dementia in Canada.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=522651

Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=522651

Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=522651

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=522651

Apolipoprotein E polymorphism and atherosclerosis: insight from a study in octogenarians

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=522651

Risk factors for Alzheimer's disease: a prospective analysis from the Canadian Study of Health and Aging.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=522651

Modulation by age and gender of risk for Alzheimer's disease and vascular dementia associated with the apolipoprotein E-epsilon4 allele in Latin Americans: findings from the Maracaibo Aging Study.

25 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=522651

Apolipoprotein E epsilon4 allele is a risk factor for late-onset Alzheimer's disease and vascular dementia in Han Chinese.

25 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=522651

Vascular dementia : incidence and risk factors in the Canadian study of health and aging

25 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=522651

Increased apolipoprotein E4 allele frequency is associated with vascular dementia in the Hungarian population.

25 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=522651

ApoE-4 and age at onset of Alzheimer's disease: the NIMH genetics initiative.

25 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=522651

Apolipoprotein E epsilon4 association with dementia in a population-based study: The Framingham study.

25 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=522651

Apolipoprotein E polymorphism in Japanese patients with Alzheimer's disease or vascular dementia

25 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=522651

Prevalence and types of dementia in the very old: results from the Canadian Study of Health and Aging.

25 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=522651

Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory-impaired individuals.

25 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=522651

Apolipoprotein E phenotypes in demented and cognitively impaired patients with and without cerebrovascular disease

25 November 2018

1 reference

12 December 2020

The incidence of dementia in Canada. The Canadian Study of Health and Aging Working Group

1 reference

12 December 2020

Canadian study of health and aging: study methods and prevalence of dementia

1 reference

12 December 2020

Apolipoprotein E ε4 Allele in Alzheimer's Disease and Vascular Dementia

1 reference

12 December 2020

The Canadian Study of Health and Aging: risk factors for Alzheimer's disease in Canada

1 reference

12 December 2020

Identifiers

DOI

10.1503/CMAJ.1031789

1 reference

21 August 2017

1 reference

21 August 2017

PubMed publication ID

15477624

1 reference